SCYNEXIS (NASDAQ: SCYX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by HC Wainwright & Co. on Friday, May 13, 2022. The analyst firm set a price target for 8.00 expecting SCYX to rise to within 12 months (a possible 288.35% upside). 2 analyst firms have reported ratings in the last year.
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.06 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for SCYNEXIS.
SCYNEXIS’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for SCYNEXIS.
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.